Controlled Release by Permeability Alteration of Cationic Ammonio Methacrylate Copolymers Using Ionic Interactions

REFERENCES

• Arkinstall W. W. Review of the North American experience with evening administration of Uniphyl tablets, a once daily theophylline preparation, in the treatment of nocturnal asthma. Am. J. Med 1988; 85: 60–63
   PubMed Web of Science ®Google Scholar
• Beckert T.E., Pogarell K., Hack I., Petereit H.-U. Pulsed drug release with film coating of EUDRAGIT® & Mac 226; RS30D. Proc. Int. Symp. Control. Release Bioact. Mater. 1999; 533–534
   Google Scholar
• Bodmeier R., Guo X., Sarabia R. E., Scullery P. F. The influence of buffer species and strength on Diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, EUDRAGIT® RS, RL 30D. Pharm. Res. 1996; 13(1)52–56
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. (2002) Published by British Pharmacopoeial Commission office, Vol. 1, 1673.
   Google Scholar
• Bryan J. Development of drug delivery systems that match the circadian rhythm. J. Pharm 2005; 274: 90–91
   Google Scholar
• Chandrasekaran S. K., Benson H., Urquhart J. Methods to achieve controlled drug delivery: The biomedical engineering approach. Sustained and Controlled Release Drug Delivery Systems, J. R. Robinson. Informa UK Ltd, New York 1978; 557–593
   Google Scholar
• Chang R. K., Hsiao C. EUDRAGIT® RL and RS pseudolatices: properties and performance in pharmaceutical coating as a controlled release membrane for Theophylline pellets. Drug Dev. Ind. Pharm. 1989; 15(2)187–196
   Web of Science ®Google Scholar
• Chidambaram N., Porter W., Flood K., Qiu Y. Formulation and charachterization of new layered diffusion metrices for zero-order sustained-release. J. Control. Release 1998; 52: 149–158
   PubMed Web of Science ®Google Scholar
• Conte U., Maggi M. A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets. J. Control. Release 2000; 64: 263–268
   PubMed Web of Science ®Google Scholar
• Cortese, R., Theeuwes, F. (1982) Osmotic device with hydrogel driving member. U. S. Patent 4,327,725, May 4, 1982.
   Google Scholar
• Gillian C. A., Wan P. A. L. Factors affecting drug release from a pellet system coated with an aqueous colloidal dispersion. Int. J. Pharm 1991; 73: 51–68
   Google Scholar
• Lee L. Diffusion-controlled Matrix systems. Treatise on controlled drug delivery, A. Kydonicus. Informa UK Ltd, New York 1992; 115–198
   Google Scholar
• Lee P. I. Kinetics of drug release from the hydrogel metrices. J. Control. Release 1985; 2: 277–288
   Google Scholar
• Lu E., Jiang Z., Zhang Q., Jiang X. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J. Control. Release 2003; 92: 375–382
   PubMed Web of Science ®Google Scholar
• Maggi, L., Shepard, T., Rochdi, M., Grenier, P., Halbeisen, S., Zimmer, R., & Conte, U. (1997) A simulation approach for effective development of a naproxen Geomatrix Quick/Slow formulation. Proc. Of the 24th Int. Symp. Control. Release Bioact. Mater. Stockholm, Sweden, June 15–19, 1997, 327–328.
   Google Scholar
• Narasimhan B., Langer R. Zero-order release of micro and macromolecules from polymeric devices: the role of the burst effect. J. Control. Release 1997; 47: 13–20
   Web of Science ®Google Scholar
• Narisawa S., Nagata M., Danyoshi C., Yoshino H., Murata K., Hirakawa Y., Noda K. An organic acid-induced sigmoidal release system for oral controlled release preparations. Pharm. Res 1994; 11(1)111–116
   PubMed Web of Science ®Google Scholar
• Narisawa S., Nagata M., Hirakawa Y., Kobayashi M., Yoshino H. An organic acid- induced sigmoidal release system for oral controlled release preparations permeability enhancement of EUDRAGIT® RS coating led by the physicochemical interactions with organic acid. J. Pharm. Sci 1996; 85(2)184–188
   PubMed Web of Science ®Google Scholar
• Narisawa S., Nagata M., Ito T., Yoshino H., Hirakawa Y., Noda K. Drug release behaviour in gastrointestinal tract of beagle dogs from multiple unit type rate controlled or time controlled release preparations coated with insoluble polymer based films. J. Control. Release 1995; 33: 253–260
   Web of Science ®Google Scholar
• Okar R. S. Effect of polymer cation content on certain film properties. J. Pharm. Pharmacol 1982; 34: 88–92
   Google Scholar
• Peppas N. A. Hydrogels in Medicine and Pharmacy. Informa UK Ltd, Boca Raton, FL 1998; Vols I, II and III
   Google Scholar
• Peppas N. A., Sahlin J. J. A simple equation for the description of the solute release: III. Coupling of diffusion and relaxation. Int. J. Pharm 1989; 57: 169–172
   Web of Science ®Google Scholar
• Petereit H.-U., Assmus M., Lehman K. Glycerol Monostearate as a glidant in aqueous film-coating formulations. Eur. J. Pharm. & Biopharm 1995; 41(4)219–228
   Web of Science ®Google Scholar
• Petereit, H. U., Beckert, T., & Lynenskjolt, E. (2000) Coated medicament forms with controlled active substance release. W O Patent 0019984, April 13, 2000.
   Google Scholar
• Ravishankar, H., & Renner, G. (2005) In-vivo evaluation of EUDRAMODE™: A novel diffusion controlled multiple unit drug delivery system. Transactions of 32nd Annual Meeting and Exposition of Controlled Release Society, Miami, FL, June 18–22, 2005, 161.
   Google Scholar
• Santus G., Baker R. W. Osmotic drug delivery: A review of the patent literature. J. Control. Release 1995; 35: 1–21
   Web of Science ®Google Scholar
• Smith D. H., Neutel J. M., Weber M. A. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am. J. Hypertens 2001; 14: 14–19
   PubMed Web of Science ®Google Scholar
• Stephens S. I., Wong P. S. L. Dosage form with improved delivery capability. U. S. Patent 4,863,456, September 5, 1989, (1989)
   Google Scholar
• Talukder R., Fassihi R. Gastroretentive Delivery systems: A mini review. Drug Dev. Ind. Pharm 2004; 30(10)1019–1028
   PubMed Web of Science ®Google Scholar
• Theeuwes F. Osmotic system for the controlled and delivery of agent over time. U. S. Patent 4,111,202, September 5, 1978, (1978)
   Google Scholar
• Verma R. K., Krishna D. M., Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 2002; 79: 7–27
   PubMed Web of Science ®Google Scholar
• Verma R. K., Mishra B., Garg S. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm 2000; 26(7)695–708
   PubMed Web of Science ®Google Scholar
• Wagner K. G., McGinity J. W. Influence of chloride ion exchange on the permeability and drug release of EUDRAGIT® RS30D films. J. Control. Release 2002; 82(2)385–397
   PubMed Web of Science ®Google Scholar
• Youan B. Chronotherapeutics: gimmick or clinically relevant approach to drug delivery?. J. Control. Release 2004; 98: 337–353
   PubMed Web of Science ®Google Scholar